Related Experiment Videos

Clinical experience with treatment of melioidosis in children

Pagakrong Lumbiganon1, Napaporn Chotechuangnirun, Pope Kosalaraksa

  • 1Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Insights

This study evaluated treatments for childhood melioidosis, finding that ceftazidime and trimethoprim-sulfamethoxazole were effective. Most children treated for melioidosis (a bacterial infection) recovered well.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Microbiology

Background:

  • Melioidosis is a serious bacterial infection caused by Burkholderia pseudomallei.
  • Pediatric melioidosis presents diagnostic and therapeutic challenges.

Purpose of the Study:

  • To report treatment and follow-up outcomes for children diagnosed with melioidosis.
  • To evaluate the efficacy and safety of antimicrobial regimens used.

Main Methods:

  • Retrospective analysis of 30 children with culture-proven melioidosis (1994-1999).
  • Treatment regimens included ceftazidime, trimethoprim-sulfamethoxazole, and doxycycline.
  • Patients were categorized by disease presentation: septicemia (12) and localized infection (18).

Main Results:

  • Ceftazidime, often combined with trimethoprim-sulfamethoxazole, was used for acute severe cases.
  • Oral trimethoprim-sulfamethoxazole or doxycycline combinations were used for eradication or localized treatment.
  • Of 25 followed patients, 24 showed a good recovery; three sudden deaths occurred.

Conclusions:

  • Antimicrobial therapy, including ceftazidime and trimethoprim-sulfamethoxazole, demonstrated effectiveness in treating pediatric melioidosis.
  • The observed outcomes suggest favorable prognosis with appropriate treatment, despite some mortality.